Financing, Equity Capital Markets

Kinnate Biopharma Inc.

12/20
|
$276.0 Million
Piper Sandler served as bookrunner for Kinnate Biopharma Inc. on its initial public offering
Sub-Type
IPO
Sub-Sector
Biopharma